Link to this page
National Drug File - Reference Terminology
Last uploaded:
July 6, 2018
| Id | http://purl.bioontology.org/ontology/NDFRT/N0000006101
http://purl.bioontology.org/ontology/NDFRT/N0000006101
|
|---|---|
| Preferred Name | Selegiline [Chemical/Ingredient] |
| Synonyms |
L-Deprenyl
Benzeneethanamine, N,alpha-dimethyl-N-2-propynyl-, (R)-
Selegiline, (R)-Isomer
Selegyline
Selegiline
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| altLabel |
L-Deprenyl
Benzeneethanamine, N,alpha-dimethyl-N-2-propynyl-, (R)-
Selegiline, (R)-Isomer
Selegyline
Selegiline
|
|---|---|
| prefLabel | Selegiline [Chemical/Ingredient]
|
| MESH DEFINITION | A selective, irreversible inhibitor of Type B monoamine oxidase. It is used in newly diagnosed patients with Parkinson's disease. It may slow progression of the clinical disease and delay the requirement for levodopa therapy. It also may be given with levodopa upon onset of disability. (From AMA Drug Evaluations Annual, 1994, p385) The compound without isomeric designation is Deprenyl.
|
| MESH DUI | D012642
|
| MESH UI | M0019601
|
| MeSH name | Selegiline
|
| type | |
| tui |
T109
T121
|
| notation | N0000006101
|
| Semantic type UMLS property | |
| NUI | N0000006101
|
| Ingredient of | |
| cui | C0036579
|
| NDFRT kind | INGREDIENT_KIND
|
| subClassOf |
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |